查看購物車
  • English
  • Japanese
缺血性壞死市場規模、佔有率和成長分析：按治療方法、分期、最終用戶和地區分類－2026-2033年產業預測
市場調查報告書
商品編碼
2065276

缺血性壞死市場規模、佔有率和成長分析：按治療方法、分期、最終用戶和地區分類－2026-2033年產業預測

Avascular Necrosis Market Size, Share, and Growth Analysis, By Treatment Type (Surgical, Non-Surgical), By Stage (Early Stage (I-II), Late Stage (III-IV)), By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球缺血性壞死市場價值為 485.25 億美元，預計到 2025 年將成長至 519.315 億美元，到 2033 年將成長至 898.54 億美元，在預測期（2026-2033 年）內複合年成長率為 7.02%。

全球缺血性壞死（AVN）市場的主要驅動力是老年人和類固醇使用者中骨壞死盛行率的不斷上升。這些患者通常伴隨多種健康問題，加劇關節劣化。該市場涵蓋診斷、手術治療、藥物治療和復健策略。未經治療的AVN會導致關節崩壞，造成嚴重的經濟負擔和生活品質下降等問題，因此有效的治療至關重要。近期趨勢表明，治療重點正從對症治療轉向以早期影像學​​技術為重點的關節保護，例如MRI技術的進步以及將髓芯減壓手術與生物製藥相結合的聯合手術。這些技術的整合能夠早期發現無症狀病例，從而增加對旨在保護關節的治療方法的需求。此外，微創手術的進步和保險覆蓋範圍的擴大預計將進一步拓寬患者接受治療的機會。

全球缺血性壞死市場成長要素

全球缺血性壞死市場擴張主要得益於外科技術的進步。這些進步改善了患者的治療效果，並增強了臨床醫生治療疾病的信心。隨著手術方法可預測性的提高，越來越多的醫療機構開始採用這些技術，並投資必要的設備和人員培訓。隨著外科醫生不斷改進微創和關節保留技術，早期手術干預的趨勢日益增強，轉診模式也在發生變化，對植入和再生醫學材料的需求預計將會增加。這種轉變將促進整合式醫療路徑的形成，從而推動市場更廣泛的接受度和成長。

全球缺血性壞死市場面臨的限制因素

全球缺血性壞死市場面臨嚴峻挑戰，其中高昂的手術費用和植入醫療器材成本是高成本，可能阻礙創新技術的應用。醫療支付者和醫療系統通常優先考慮成本控制，限制對新技術的保險報銷，並傾向於選擇已驗證有效的成熟方案。即使有臨床證據支持其有效性，這種趨勢也阻礙了新技術的推廣應用。此外，患者和醫院需要自付費用，以及培訓和設備方面的必要投資，都會進一步阻礙新治療方法融入常規診療流程，最終限制市場成長。

全球缺血性壞死市場趨勢

全球缺血性壞死（AVN）市場正經歷著向生物製藥植入、生長因子應用和支架材料的出現，凸顯了研究人員和臨床醫生為開發創新治療方法以加速骨癒合和減少侵入性手術需求而進行的合作努力。儘管整形外科公司和生技公司之間的合作推動了臨床研發的蓬勃發展，但醫療服務提供者也越來越重視長期治療效果，這表明生物製劑在AVN治療中的應用日益受到認可。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球缺血性壞死市場規模：依治療類型分類

  • 手術治療
    • 藥物治療（非類固醇抗發炎藥、雙磷酸鹽類藥物）
    • 物理治療
    • 電刺激
  • 非手術治療

全球缺血性壞死市場規模：依階段分類

  • 初始階段（I-II）
  • 晚期（III-IV期）

全球缺血性壞死市場規模：依最終用戶分類

  • 醫院
  • 整形外科診所
  • 復健中心

全球缺血性壞死市場規模：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析，2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較（2023-2025 年）

主要公司簡介

  • Zimmer Biomet
  • Stryker Corporation
  • DePuy Synthes（J&J）
  • Smith & Nephew
  • Wright Medical Group
  • Exactech Inc.
  • Pfizer Inc.
  • Novartis AG
  • Amgen Inc.
  • Eli Lilly and Company
  • Medtronic
  • Bioventus LLC
  • Arthrex Inc.
  • Conformis Inc.
  • Merete Medical GmbH

結論與建議

簡介目錄
Product Code: SQMIG35I2807

Global Avascular Necrosis Market size was valued at USD 4852.50 Million in 2024 and is poised to grow from USD 5193.15 Million in 2025 to USD 8985.40 Million by 2033, growing at a CAGR of 7.02% during the forecast period (2026-2033).

The global avascular necrosis (AVN) market is primarily driven by the increasing prevalence of osteonecrosis in older populations and steroid users, who typically present with multiple health issues that exacerbate joint deterioration. This market encompasses diagnostics, surgical, pharmaceutical treatments, and rehabilitation strategies. Effective treatment is critical, as untreated AVN can lead to joint collapse, imposing significant financial and quality of life burdens. Recent trends highlight a shift from symptom management to early imaging techniques that focus on joint preservation, exemplified by MRI advancements and combined procedures like core decompression with biologics. The integration of technology facilitates early detection of asymptomatic cases, amplifying the demand for joint-preserving interventions. Additionally, enhancements in minimally invasive surgeries and expanded reimbursement models will broaden patient access to care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Avascular Necrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Avascular Necrosis Market Segments Analysis

Global avascular necrosis market is segmented by treatment type, stage, end-user and region. Based on treatment type, the market is segmented into surgical and non-surgical. Based on stage, the market is segmented into early stage (I-II) and late stage (III-IV). Based on end-user, the market is segmented into hospitals, orthopedic clinics and rehabilitation centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Avascular Necrosis Market

The expansion of the global avascular necrosis market is significantly influenced by advancements in surgical techniques, which have improved patient outcomes and enhanced clinician confidence in treating this condition. With the increasing predictability of surgical approaches, more healthcare facilities are adopting these procedures and investing in necessary equipment and staff training. As surgeons refine minimally invasive and joint-preserving techniques, the trend toward earlier surgical intervention is likely to evolve referral patterns, leading to heightened demand for implants and regenerative materials. This shift fosters integrated care pathways, promoting wider acceptance and growth within the market.

Restraints in the Global Avascular Necrosis Market

The Global Avascular Necrosis market faces significant challenges due to the high costs associated with advanced surgical procedures and implantable devices, which may impede the adoption of innovative technologies. Healthcare payers and systems often prioritize cost containment, leading to restricted reimbursements for new technologies and a preference for established solutions that already demonstrate success. This focus creates a disincentive to embrace novel advancements, despite available clinical evidence supporting their efficacy. Additionally, the financial burden on patients and hospitals related to out-of-pocket expenses and the necessary investment in training and equipment presents further obstacles to integrating new therapies into standard care practices, thereby limiting market growth.

Market Trends of the Global Avascular Necrosis Market

The global market for Avascular Necrosis (AVN) is witnessing a transformative trend towards biologics and regenerative therapies, driven by a shift in clinical focus towards preserving joint function and enhancing patient quality of life. The emergence of bioengineered implants, growth factor applications, and scaffolding materials underscores a concerted effort among researchers and clinicians to develop innovative treatments that promote bone healing and reduce the need for invasive surgeries. Collaboration between orthopedic and biotechnology firms is fostering a surge in clinical research and product development, while healthcare providers increasingly prioritize long-term outcomes, signaling a growing acceptance of biologic solutions in the management of AVN.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Avascular Necrosis Market Size by Treatment Type & CAGR (2026-2033)

  • Market Overview
  • Surgical
    • Medications (NSAIDs, Bisphosphonates)
    • Physical Therapy
    • Electrical Stimulation
  • Non-Surgical

Global Avascular Necrosis Market Size by Stage & CAGR (2026-2033)

  • Market Overview
  • Early Stage (I-II)
  • Late Stage (III-IV)

Global Avascular Necrosis Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Orthopedic Clinics
  • Rehabilitation Centers

Global Avascular Necrosis Market Size & CAGR (2026-2033)

  • North America (Treatment Type, Stage, End-User)
    • US
    • Canada
  • Europe (Treatment Type, Stage, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Stage, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Stage, End-User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Stage, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Zimmer Biomet
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DePuy Synthes (J&J)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wright Medical Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Exactech Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioventus LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arthrex Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conformis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merete Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations